Evidence map›Paper›PMID 40060915›Full record

ArticleJBMR plus2025

Hearing loss predictive model in fibrodysplasia ossificans progressiva from a national referral center: developing an hearing loss predictive model.

Tommaso Cacco, Riccardo Papa, Luca Carmisciano, Carola Bruzzo, Lucia Semino, Alberto Tonelli, Caterina Matucci-Cerinic, Maja Di Rocco, Renata Bocciardi, Marco Gattorno and 1 more

Abstract read
In one paragraph

Article in JBMR plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tommaso CaccoOtorhinolaryngology Unit, IRCCS Istituto Giannina Gaslini, 16132 Genova, Italy.ORCID https://orcid.org/0000-0002-2818-1742
Riccardo PapaRheumatology and Autoinflammatory Diseases Unit, IRCCS Istituto Giannina Gaslini, 16132 Genova, Italy.
Luca CarmiscianoDepartment of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
Carola BruzzoOtorhinolaryngology Unit, IRCCS Istituto Giannina Gaslini, 16132 Genova, Italy.
Lucia SeminoOtorhinolaryngology Unit, IRCCS Istituto Giannina Gaslini, 16132 Genova, Italy.
Alberto TonelliOtorhinolaryngology Unit, IRCCS Istituto Giannina Gaslini, 16132 Genova, Italy.
Caterina Matucci-CerinicRheumatology and Autoinflammatory Diseases Unit, IRCCS Istituto Giannina Gaslini, 16132 Genova, Italy.
Maja Di RoccoRare Diseases Unit, IRCCS Istituto Giannina Gaslini, 16132 Genova, Italy.
Renata BocciardiMedical Genetics Unit, IRCCS Istituto Giannina Gaslini, 16132 Genova, Italy.
Marco GattornoRheumatology and Autoinflammatory Diseases Unit, IRCCS Istituto Giannina Gaslini, 16132 Genova, Italy.
Roberto D'AgostinoOtorhinolaryngology Unit, IRCCS Istituto Giannina Gaslini, 16132 Genova, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrodysplasia ossificans progressiva (FOP) is the most dramatic form of progressive heterotopic ossification of soft tissues. Hearing impairment in FOP patient is a common feature, reported by about 50% of affected patients. However, wide case series considering audiologic features are lacking. We report the audiologic history of a group of FOP patients in order to define the hearing loss characteristics, genotype association, and possible rehabilitative options. We report audiometric history of 16 FOP patients referred to our Institute from 2014 onwards without ear malformations or other known reason for audiologic impairment. Major involvement of high frequencies in our FOP cohort suggests that the position of the high-frequency receptors within the cochlea, near the oval window, makes them more exposed to damage than the low-frequency receptors located deeper in the cochlea. Furthermore, the reported gender difference may be secondary to a hormonal effect, as known in patients with otosclerosis. Finally, regarding the genotype, we noted that only the non-classic patient carrying the

Indexed as

audiologybone diseasefibrodysplasia ossificans progressivahearing rehabilitationstatistical model

Identifiers

PMID40060915
PMCPMC11890112

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.